VBI Vaccines Current Debt
VBIVQ Stock | 0.0005 0.0001 16.67% |
As of 12/26/2024, Short and Long Term Debt is likely to drop to about 36.1 M. In addition to that, Long Term Debt is likely to drop to about 34.3 M. VBI Vaccines' financial risk is the risk to VBI Vaccines stockholders that is caused by an increase in debt.
Given that VBI Vaccines' debt-to-equity ratio measures a Company's obligations relative to the value of its net assets, it is usually used by traders to estimate the extent to which VBI Vaccines is acquiring new debt as a mechanism of leveraging its assets. A high debt-to-equity ratio is generally associated with increased risk, implying that it has been aggressive in financing its growth with debt. Another way to look at debt-to-equity ratios is to compare the overall debt load of VBI Vaccines to its assets or equity, showing how much of the company assets belong to shareholders vs. creditors. If shareholders own more assets, VBI Vaccines is said to be less leveraged. If creditors hold a majority of VBI Vaccines' assets, the Company is said to be highly leveraged.
As of 12/26/2024, Total Current Liabilities is likely to drop to about 44.7 M. In addition to that, Non Current Liabilities Total is likely to drop to about 3.5 MVBI |
VBI Vaccines Financial Rating
VBI Vaccines financial ratings play a critical role in determining how much VBI Vaccines have to pay to access credit markets, i.e., the amount of interest on their issued debt. The threshold between investment-grade and speculative-grade ratings has important market implications for VBI Vaccines' borrowing costs.Piotroski F Score | 2 | Frail | View |
Beneish M Score | (4.01) | Unlikely Manipulator | View |
VBI Vaccines Short Long Term Debt Over Time
VBI Vaccines Assets Financed by Debt
Typically, companies with high debt-to-asset ratios are said to be highly leveraged. The higher the ratio, the greater risk will be associated with the VBI Vaccines' operation. In addition, a high debt-to-assets ratio may indicate a low borrowing capacity of VBI Vaccines, which in turn will lower the firm's financial flexibility.VBI Short Long Term Debt
Short Long Term Debt |
|
Understaning VBI Vaccines Use of Financial Leverage
VBI Vaccines' financial leverage ratio measures its total debt position, including all of its outstanding liabilities, and compares it to VBI Vaccines' current equity. If creditors own a majority of VBI Vaccines' assets, the company is considered highly leveraged. Understanding the composition and structure of VBI Vaccines' outstanding bonds gives an idea of how risky it is and if it is worth investing in.
Last Reported | Projected for Next Year | ||
Short and Long Term Debt | 58.4 M | 36.1 M | |
Long Term Debt | 56.2 M | 34.3 M | |
Net Debt | 24.4 M | 21.7 M |
Pair Trading with VBI Vaccines
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if VBI Vaccines position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in VBI Vaccines will appreciate offsetting losses from the drop in the long position's value.Moving together with VBI Stock
Moving against VBI Stock
0.53 | EPRX | Eupraxia Pharmaceuticals | PairCorr |
0.48 | GRCE | Grace Therapeutics, Symbol Change | PairCorr |
0.44 | FBIOP | Fortress Biotech Pref | PairCorr |
0.39 | FRTX | Fresh Tracks Therapeutics | PairCorr |
0.37 | UPB | Upstream Bio, | PairCorr |
The ability to find closely correlated positions to VBI Vaccines could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace VBI Vaccines when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back VBI Vaccines - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling VBI Vaccines to buy it.
The correlation of VBI Vaccines is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as VBI Vaccines moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if VBI Vaccines moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for VBI Vaccines can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Additional Tools for VBI Stock Analysis
When running VBI Vaccines' price analysis, check to measure VBI Vaccines' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy VBI Vaccines is operating at the current time. Most of VBI Vaccines' value examination focuses on studying past and present price action to predict the probability of VBI Vaccines' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move VBI Vaccines' price. Additionally, you may evaluate how the addition of VBI Vaccines to your portfolios can decrease your overall portfolio volatility.
What is Financial Leverage?
Financial leverage is the use of borrowed money (debt) to finance the purchase of assets with the expectation that the income or capital gain from the new asset will exceed the cost of borrowing. In most cases, the debt provider will limit how much risk it is ready to take and indicate a limit on the extent of the leverage it will allow. In the case of asset-backed lending, the financial provider uses the assets as collateral until the borrower repays the loan. In the case of a cash flow loan, the general creditworthiness of the company is used to back the loan. The concept of leverage is common in the business world. It is mostly used to boost the returns on equity capital of a company, especially when the business is unable to increase its operating efficiency and returns on total investment. Because earnings on borrowing are higher than the interest payable on debt, the company's total earnings will increase, ultimately boosting stockholders' profits.Leverage and Capital Costs
The debt to equity ratio plays a role in the working average cost of capital (WACC). The overall interest on debt represents the break-even point that must be obtained to profitability in a given venture. Thus, WACC is essentially the average interest an organization owes on the capital it has borrowed for leverage. Let's say equity represents 60% of borrowed capital, and debt is 40%. This results in a financial leverage calculation of 40/60, or 0.6667. The organization owes 10% on all equity and 5% on all debt. That means that the weighted average cost of capital is (.4)(5) + (.6)(10) - or 8%. For every $10,000 borrowed, this organization will owe $800 in interest. Profit must be higher than 8% on the project to offset the cost of interest and justify this leverage.Benefits of Financial Leverage
Leverage provides the following benefits for companies:- Leverage is an essential tool a company's management can use to make the best financing and investment decisions.
- It provides a variety of financing sources by which the firm can achieve its target earnings.
- Leverage is also an essential technique in investing as it helps companies set a threshold for the expansion of business operations. For example, it can be used to recommend restrictions on business expansion once the projected return on additional investment is lower than the cost of debt.